Dean: Supreme Court has weakened U.S. patents, cue Congress

When the world experienced a hard season of flu and respiratory illness in 2021 and 2022, European firms launched convenient, three-in-one tests for the flu, COVID, and RSV. Americans were left wondering why they weren't coming out of U.S. labs.

Related Keywords

United States ,American ,Americans ,America , ,Alice Corp ,Association For Molecular Pathology ,Bank International ,Supreme Court ,Mayo Collaborative Services ,Affordable Care ,Prometheus Labs ,Mayo Clinic ,Molecular Pathology ,Senators Chris Coons ,Thom Tillis ,Patents ,Diagnostic Tests ,Competition ,Covid ,Rsv ,Flu ,Congress ,Senator Chris Coons ,Senator Thom Tillis ,